Literature DB >> 24900689

PAK1: A Therapeutic Target for Cancer Treatment.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2013        PMID： 24900689      PMCID： PMC4027248          DOI： 10.1021/ml400101g

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 2.  Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.

Authors:  Chunling Yi; Jasna Maksimoska; Ronen Marmorstein; Joseph L Kissil
Journal:  Biochem Pharmacol       Date:  2010-03-17       Impact factor: 5.858

Review 3.  p21-activated kinase 1: PAK'ed with potential.

Authors:  Christy C Ong; Adrian M Jubb; Wei Zhou; Peter M Haverty; Adrian L Harris; Marcia Belvin; Lori S Friedman; Hartmut Koeppen; Klaus P Hoeflich
Journal:  Oncotarget       Date:  2011-06
  3 in total
  2 in total

1.  Essential oil of Pinus koraiensis inhibits cell proliferation and migration via inhibition of p21-activated kinase 1 pathway in HCT116 colorectal cancer cells.

Authors:  Sun-Mi Cho; Eun-Ok Lee; Sung-Hoon Kim; Hyo-Jeong Lee
Journal:  BMC Complement Altern Med       Date:  2014-07-30       Impact factor: 3.659

2.  Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer.

Authors:  Dahong Yao; Jian Huang; Jinhui Wang; Zhendan He; Jin Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.